img

Global Glutamate Receptor Ionotropic NMDA 2B Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Glutamate Receptor Ionotropic NMDA 2B Market Research Report 2024

According to Mr Accuracy reports’s new survey, global Glutamate Receptor Ionotropic NMDA 2B market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Glutamate Receptor Ionotropic NMDA 2B market research.
Key manufacturers engaged in the Glutamate Receptor Ionotropic NMDA 2B industry include BioCrea GmbH, Bristol-Myers Squibb Company, Cerecor Inc., Johnson & Johnson, Luc Therapeutics, Inc., NeurOp, Inc, Novartis AG and UCB S.A., etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Glutamate Receptor Ionotropic NMDA 2B were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Glutamate Receptor Ionotropic NMDA 2B market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Glutamate Receptor Ionotropic NMDA 2B market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


BioCrea GmbH
Bristol-Myers Squibb Company
Cerecor Inc.
Johnson & Johnson
Luc Therapeutics, Inc.
NeurOp, Inc
Novartis AG
UCB S.A.
Segment by Type
JNJ-0808
Neu-2000
NP-10679
NP-11948
Radiprodil
Others

Segment by Application


Acute Ischemic Stroke
Autism
Brain Ischemia
Burns
Others

Consumption by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Glutamate Receptor Ionotropic NMDA 2B report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Glutamate Receptor Ionotropic NMDA 2B Market Overview
1.1 Product Overview and Scope of Glutamate Receptor Ionotropic NMDA 2B
1.2 Glutamate Receptor Ionotropic NMDA 2B Segment by Type
1.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Value Comparison by Type (2024-2034)
1.2.2 JNJ-0808
1.2.3 Neu-2000
1.2.4 NP-10679
1.2.5 NP-11948
1.2.6 Radiprodil
1.2.7 Others
1.3 Glutamate Receptor Ionotropic NMDA 2B Segment by Application
1.3.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Value by Application: (2024-2034)
1.3.2 Acute Ischemic Stroke
1.3.3 Autism
1.3.4 Brain Ischemia
1.3.5 Burns
1.3.6 Others
1.4 Global Glutamate Receptor Ionotropic NMDA 2B Market Size Estimates and Forecasts
1.4.1 Global Glutamate Receptor Ionotropic NMDA 2B Revenue 2018-2034
1.4.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales 2018-2034
1.4.3 Global Glutamate Receptor Ionotropic NMDA 2B Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Glutamate Receptor Ionotropic NMDA 2B Market Competition by Manufacturers
2.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Manufacturers (2018-2024)
2.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Glutamate Receptor Ionotropic NMDA 2B Average Price by Manufacturers (2018-2024)
2.4 Global Glutamate Receptor Ionotropic NMDA 2B Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Glutamate Receptor Ionotropic NMDA 2B, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Glutamate Receptor Ionotropic NMDA 2B, Product Type & Application
2.7 Glutamate Receptor Ionotropic NMDA 2B Market Competitive Situation and Trends
2.7.1 Glutamate Receptor Ionotropic NMDA 2B Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Glutamate Receptor Ionotropic NMDA 2B Players Market Share by Revenue
2.7.3 Global Glutamate Receptor Ionotropic NMDA 2B Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Glutamate Receptor Ionotropic NMDA 2B Retrospective Market Scenario by Region
3.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Glutamate Receptor Ionotropic NMDA 2B Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region: 2018-2034
3.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region: 2018-2024
3.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region: 2024-2034
3.3 Global Glutamate Receptor Ionotropic NMDA 2B Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Region: 2018-2034
3.3.1 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Region: 2018-2024
3.3.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Region: 2024-2034
3.4 North America Glutamate Receptor Ionotropic NMDA 2B Market Facts & Figures by Country
3.4.1 North America Glutamate Receptor Ionotropic NMDA 2B Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2018-2034)
3.4.3 North America Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Glutamate Receptor Ionotropic NMDA 2B Market Facts & Figures by Country
3.5.1 Europe Glutamate Receptor Ionotropic NMDA 2B Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2018-2034)
3.5.3 Europe Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Market Facts & Figures by Country
3.6.1 Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2018-2034)
3.6.3 Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Glutamate Receptor Ionotropic NMDA 2B Market Facts & Figures by Country
3.7.1 Latin America Glutamate Receptor Ionotropic NMDA 2B Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2018-2034)
3.7.3 Latin America Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Market Facts & Figures by Country
3.8.1 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2018-2034)
3.8.3 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2018-2034)
4.1.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2018-2024)
4.1.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2024-2034)
4.1.3 Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type (2018-2034)
4.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2018-2034)
4.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2018-2024)
4.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2024-2034)
4.2.3 Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Type (2018-2034)
4.3 Global Glutamate Receptor Ionotropic NMDA 2B Price by Type (2018-2034)
5 Segment by Application
5.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2018-2034)
5.1.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2018-2024)
5.1.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2024-2034)
5.1.3 Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application (2018-2034)
5.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2018-2034)
5.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2018-2024)
5.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2024-2034)
5.2.3 Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Application (2018-2034)
5.3 Global Glutamate Receptor Ionotropic NMDA 2B Price by Application (2018-2034)
6 Key Companies Profiled
6.1 BioCrea GmbH
6.1.1 BioCrea GmbH Corporation Information
6.1.2 BioCrea GmbH Description and Business Overview
6.1.3 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2018-2024)
6.1.4 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
6.1.5 BioCrea GmbH Recent Developments/Updates
6.2 Bristol-Myers Squibb Company
6.2.1 Bristol-Myers Squibb Company Corporation Information
6.2.2 Bristol-Myers Squibb Company Description and Business Overview
6.2.3 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
6.2.5 Bristol-Myers Squibb Company Recent Developments/Updates
6.3 Cerecor Inc.
6.3.1 Cerecor Inc. Corporation Information
6.3.2 Cerecor Inc. Description and Business Overview
6.3.3 Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
6.3.5 Cerecor Inc. Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Corporation Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Luc Therapeutics, Inc.
6.5.1 Luc Therapeutics, Inc. Corporation Information
6.5.2 Luc Therapeutics, Inc. Description and Business Overview
6.5.3 Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
6.5.5 Luc Therapeutics, Inc. Recent Developments/Updates
6.6 NeurOp, Inc
6.6.1 NeurOp, Inc Corporation Information
6.6.2 NeurOp, Inc Description and Business Overview
6.6.3 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2018-2024)
6.6.4 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
6.6.5 NeurOp, Inc Recent Developments/Updates
6.7 Novartis AG
6.6.1 Novartis AG Corporation Information
6.6.2 Novartis AG Description and Business Overview
6.6.3 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
6.7.5 Novartis AG Recent Developments/Updates
6.8 UCB S.A.
6.8.1 UCB S.A. Corporation Information
6.8.2 UCB S.A. Description and Business Overview
6.8.3 UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2018-2024)
6.8.4 UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Product Portfolio
6.8.5 UCB S.A. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Glutamate Receptor Ionotropic NMDA 2B Industry Chain Analysis
7.2 Glutamate Receptor Ionotropic NMDA 2B Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Glutamate Receptor Ionotropic NMDA 2B Production Mode & Process
7.4 Glutamate Receptor Ionotropic NMDA 2B Sales and Marketing
7.4.1 Glutamate Receptor Ionotropic NMDA 2B Sales Channels
7.4.2 Glutamate Receptor Ionotropic NMDA 2B Distributors
7.5 Glutamate Receptor Ionotropic NMDA 2B Customers
8 Glutamate Receptor Ionotropic NMDA 2B Market Dynamics
8.1 Glutamate Receptor Ionotropic NMDA 2B Industry Trends
8.2 Glutamate Receptor Ionotropic NMDA 2B Market Drivers
8.3 Glutamate Receptor Ionotropic NMDA 2B Market Challenges
8.4 Glutamate Receptor Ionotropic NMDA 2B Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Glutamate Receptor Ionotropic NMDA 2B Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Glutamate Receptor Ionotropic NMDA 2B Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Glutamate Receptor Ionotropic NMDA 2B Market Competitive Situation by Manufacturers in 2022
Table 4. Global Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs) of Key Manufacturers (2018-2024)
Table 5. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Glutamate Receptor Ionotropic NMDA 2B Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Glutamate Receptor Ionotropic NMDA 2B Average Price (USD/Pcs) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Glutamate Receptor Ionotropic NMDA 2B, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Glutamate Receptor Ionotropic NMDA 2B, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Glutamate Receptor Ionotropic NMDA 2B, Product Type & Application
Table 12. Global Key Manufacturers of Glutamate Receptor Ionotropic NMDA 2B, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Glutamate Receptor Ionotropic NMDA 2B by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glutamate Receptor Ionotropic NMDA 2B as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Glutamate Receptor Ionotropic NMDA 2B Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2018-2024) & (K Pcs)
Table 18. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Region (2018-2024)
Table 19. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2024-2034) & (K Pcs)
Table 20. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Region (2024-2034)
Table 21. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Region (2018-2024)
Table 23. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Region (2024-2034)
Table 25. North America Glutamate Receptor Ionotropic NMDA 2B Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2018-2024) & (K Pcs)
Table 27. North America Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2024-2034) & (K Pcs)
Table 28. North America Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2018-2024) & (K Pcs)
Table 32. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2024-2034) & (K Pcs)
Table 33. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2018-2024) & (K Pcs)
Table 37. Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2024-2034) & (K Pcs)
Table 38. Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Glutamate Receptor Ionotropic NMDA 2B Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2018-2024) & (K Pcs)
Table 42. Latin America Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2024-2034) & (K Pcs)
Table 43. Latin America Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2018-2024) & (K Pcs)
Table 47. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2024-2034) & (K Pcs)
Table 48. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs) by Type (2018-2024)
Table 51. Global Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs) by Type (2024-2034)
Table 52. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type (2018-2024)
Table 53. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type (2024-2034)
Table 54. Global Glutamate Receptor Ionotropic NMDA 2B Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Glutamate Receptor Ionotropic NMDA 2B Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Type (2018-2024)
Table 57. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Type (2024-2034)
Table 58. Global Glutamate Receptor Ionotropic NMDA 2B Price (USD/Pcs) by Type (2018-2024)
Table 59. Global Glutamate Receptor Ionotropic NMDA 2B Price (USD/Pcs) by Type (2024-2034)
Table 60. Global Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs) by Application (2018-2024)
Table 61. Global Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs) by Application (2024-2034)
Table 62. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application (2018-2024)
Table 63. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application (2024-2034)
Table 64. Global Glutamate Receptor Ionotropic NMDA 2B Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Glutamate Receptor Ionotropic NMDA 2B Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Application (2018-2024)
Table 67. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Application (2024-2034)
Table 68. Global Glutamate Receptor Ionotropic NMDA 2B Price (USD/Pcs) by Application (2018-2024)
Table 69. Global Glutamate Receptor Ionotropic NMDA 2B Price (USD/Pcs) by Application (2024-2034)
Table 70. BioCrea GmbH Corporation Information
Table 71. BioCrea GmbH Description and Business Overview
Table 72. BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 73. BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Product
Table 74. BioCrea GmbH Recent Developments/Updates
Table 75. Bristol-Myers Squibb Company Corporation Information
Table 76. Bristol-Myers Squibb Company Description and Business Overview
Table 77. Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 78. Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Product
Table 79. Bristol-Myers Squibb Company Recent Developments/Updates
Table 80. Cerecor Inc. Corporation Information
Table 81. Cerecor Inc. Description and Business Overview
Table 82. Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 83. Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Product
Table 84. Cerecor Inc. Recent Developments/Updates
Table 85. Johnson & Johnson Corporation Information
Table 86. Johnson & Johnson Description and Business Overview
Table 87. Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 88. Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Product
Table 89. Johnson & Johnson Recent Developments/Updates
Table 90. Luc Therapeutics, Inc. Corporation Information
Table 91. Luc Therapeutics, Inc. Description and Business Overview
Table 92. Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 93. Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Product
Table 94. Luc Therapeutics, Inc. Recent Developments/Updates
Table 95. NeurOp, Inc Corporation Information
Table 96. NeurOp, Inc Description and Business Overview
Table 97. NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 98. NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Product
Table 99. NeurOp, Inc Recent Developments/Updates
Table 100. Novartis AG Corporation Information
Table 101. Novartis AG Description and Business Overview
Table 102. Novartis AG Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 103. Novartis AG Glutamate Receptor Ionotropic NMDA 2B Product
Table 104. Novartis AG Recent Developments/Updates
Table 105. UCB S.A. Corporation Information
Table 106. UCB S.A. Description and Business Overview
Table 107. UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 108. UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Product
Table 109. UCB S.A. Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Glutamate Receptor Ionotropic NMDA 2B Distributors List
Table 113. Glutamate Receptor Ionotropic NMDA 2B Customers List
Table 114. Glutamate Receptor Ionotropic NMDA 2B Market Trends
Table 115. Glutamate Receptor Ionotropic NMDA 2B Market Drivers
Table 116. Glutamate Receptor Ionotropic NMDA 2B Market Challenges
Table 117. Glutamate Receptor Ionotropic NMDA 2B Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Glutamate Receptor Ionotropic NMDA 2B
Figure 2. Global Glutamate Receptor Ionotropic NMDA 2B Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Glutamate Receptor Ionotropic NMDA 2B Market Share by Type in 2022 & 2034
Figure 4. JNJ-0808 Product Picture
Figure 5. Neu-2000 Product Picture
Figure 6. NP-10679 Product Picture
Figure 7. NP-11948 Product Picture
Figure 8. Radiprodil Product Picture
Figure 9. Others Product Picture
Figure 10. Global Glutamate Receptor Ionotropic NMDA 2B Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 11. Global Glutamate Receptor Ionotropic NMDA 2B Market Share by Application in 2022 & 2034
Figure 12. Acute Ischemic Stroke
Figure 13. Autism
Figure 14. Brain Ischemia
Figure 15. Burns
Figure 16. Others
Figure 17. Global Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 18. Global Glutamate Receptor Ionotropic NMDA 2B Market Size (2018-2034) & (US$ Million)
Figure 19. Global Glutamate Receptor Ionotropic NMDA 2B Sales (2018-2034) & (K Pcs)
Figure 20. Global Glutamate Receptor Ionotropic NMDA 2B Average Price (USD/Pcs) & (2018-2034)
Figure 21. Glutamate Receptor Ionotropic NMDA 2B Report Years Considered
Figure 22. Glutamate Receptor Ionotropic NMDA 2B Sales Share by Manufacturers in 2022
Figure 23. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Manufacturers in 2022
Figure 24. The Global 5 and 10 Largest Glutamate Receptor Ionotropic NMDA 2B Players: Market Share by Revenue in 2022
Figure 25. Glutamate Receptor Ionotropic NMDA 2B Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 26. Global Glutamate Receptor Ionotropic NMDA 2B Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 27. North America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Country (2018-2034)
Figure 28. North America Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Country (2018-2034)
Figure 29. U.S. Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Canada Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Country (2018-2034)
Figure 32. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Country (2018-2034)
Figure 33. Germany Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. France Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. U.K. Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. Italy Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. Russia Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Region (2018-2034)
Figure 39. Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Region (2018-2034)
Figure 40. China Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Japan Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. South Korea Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. India Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Australia Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Taiwan Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Indonesia Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Thailand Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Malaysia Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Philippines Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Latin America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Country (2018-2034)
Figure 51. Latin America Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Country (2018-2034)
Figure 52. Mexico Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Brazil Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. Argentina Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 55. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Country (2018-2034)
Figure 56. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Country (2018-2034)
Figure 57. Turkey Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 58. Saudi Arabia Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 59. U.A.E Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 60. Global Sales Market Share of Glutamate Receptor Ionotropic NMDA 2B by Type (2018-2034)
Figure 61. Global Revenue Market Share of Glutamate Receptor Ionotropic NMDA 2B by Type (2018-2034)
Figure 62. Global Glutamate Receptor Ionotropic NMDA 2B Price (USD/Pcs) by Type (2018-2034)
Figure 63. Global Sales Market Share of Glutamate Receptor Ionotropic NMDA 2B by Application (2018-2034)
Figure 64. Global Revenue Market Share of Glutamate Receptor Ionotropic NMDA 2B by Application (2018-2034)
Figure 65. Global Glutamate Receptor Ionotropic NMDA 2B Price (USD/Pcs) by Application (2018-2034)
Figure 66. Glutamate Receptor Ionotropic NMDA 2B Value Chain
Figure 67. Glutamate Receptor Ionotropic NMDA 2B Production Process
Figure 68. Channels of Distribution (Direct Vs Distribution)
Figure 69. Distributors Profiles
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed